- Home »
- Quarterly Results »
- RPG Life Sciences Q1 Results Total Income Reaches ₹16,779 Lakhs and Profit After Tax at ₹2,676 Lakhs
RPG Life Sciences Q1 Results Total Income Reaches ₹16,779 Lakhs and Profit After Tax at ₹2,676 Lakhs
RPG Life Sciences Q1 Results reported a 30.54% QoQ increase in Total Income to ₹16,779 lakhs, Operating Profit of ₹33.78 Cr., a 102.54% YoY rise in Profit After Tax to ₹2,676 lakhs, and an Operating Margin of 20.42%. RPG Life Sciences Q1 Results reflect strong financial growth.
by P Nandhini
Updated Sep 12, 2024
Table of Content
RPG Life Sciences Q1 Results 2024 - 2025: RPG Life Sciences announced their Q1 results on July 19, 2024, showing a significant increase in revenue. The company reported a revenue of ₹16,542 lakhs for the quarter ended June 30, 2024, which is up by 30.54% compared to the ₹12,699 lakhs recorded in the previous quarter.
This rise in revenue is a positive sign for RPG Life Sciences, reflecting strong performance and growth in their operations. You’ll notice that the increase in revenue was driven by higher sales across various product segments.
In terms of profitability, RPG Life Sciences saw an impressive boost. The profit for the period rose to ₹2,676 lakhs, which is a 102.54% increase year-over-year from ₹1,324 lakhs in the same quarter of the previous year.
The earnings per share also more than doubled, reaching ₹16.18, compared to ₹8.01 last quarter. You can see that the company's overall financial health improved significantly, with a quarter-over-quarter (QoQ) increase in profit before tax and total comprehensive income.
These results indicate a strong start to the fiscal year 2024 - 2025, positioning RPG Life Sciences well for future growth.
For More Q1 results check our Twitter Page
RPG Life Sciences Q1 Results 2024 - 2025
| Particulars | 30-Jun-24 (Unaudited) | 31-Mar-24 (Audited) |
|---|---|---|
| Revenue from Operations | ₹16,542 lakhs | ₹12,699 lakhs |
| Other Income | ₹237 lakhs | ₹165 lakhs |
| Total Income | ₹16,779 lakhs | ₹12,864 lakhs |
| Total Expenses | ₹13,179 lakhs | ₹11,090 lakhs |
| Profit Before Tax | ₹3,600 lakhs | ₹1,774 lakhs |
| Income Tax Expenses | ₹924 lakhs | ₹450 lakhs |
| Profit for the Period | ₹2,676 lakhs | ₹1,324 lakhs |
| Total Comprehensive Income | ₹2,677 lakhs | ₹1,264 lakhs |
| Paid-up Equity Share Capital | ₹1,323 lakhs | ₹1,323 lakhs |
| Earnings Per Share (Basic & Diluted) | ₹16.18 | ₹8.01 |
Source: Click Here
RPG Life Sciences Current Market Overview
RPG Life Sciences is currently trading at ₹2,301, with a recent gain of 1.71%. The company’s market value is ₹3,806 crore. On the stock exchange, it's listed under BSE (code: 532983) and NSE (code: RPGLIFE).
With a price-to-earnings ratio of 41.2 and a dividend yield of 0.70%, the company shows strong financial performance. Its return on capital employed (ROCE) is 34.6%, and its return on equity (ROE) is 25.5%. The stock’s highest price in recent times was ₹2,440, and the lowest was ₹1,210, with a face value of ₹8.00 per share.
| Metric | Value |
|---|---|
| Current Price | ₹2,301 |
| Market Cap | ₹3,806 Cr. |
| High / Low | ₹2,440 / ₹1,210 |
| Stock P/E | 41.2 |
| Book Value | ₹227 |
| Dividend Yield | 0.70% |
| ROCE | 34.6% |
| ROE | 25.5% |
| Face Value | ₹8.00 |
| Exchange Codes | BSE: 532983, NSE: RPGLIFE |
Quarterly Results
Here is a table showing RPG Life Sciences' financial performance for the quarters ending December 2023, March 2024, and June 2024:
| Metric | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|
| Sales (₹ Cr.) | 154 | 127 | 165 |
| Expenses (₹ Cr.) | 116 | 106 | 126 |
| Operating Profit (₹ Cr.) | 38 | 21 | 39 |
| OPM % | 25% | 16% | 24% |
| Other Income (₹ Cr.) | 2 | 2 | 2 |
| Interest (₹ Cr.) | 0 | 0 | 0 |
| Depreciation (₹ Cr.) | 4 | 4 | 5 |
| Profit Before Tax (₹ Cr.) | 36 | 18 | 36 |
| Tax % | 26% | 25% | 26% |
| Net Profit (₹ Cr.) | 26 | 13 | 27 |
| EPS (₹) | 16.00 | 8.01 | 16.18 |
About RPG Life Sciences
RPG Life Sciences is a company that manufactures and markets a wide range of high-value niche Active Pharmaceutical Ingredients (APIs) for global markets. Established as a part of the RPG Group, the company offers products across 13 different therapy areas, including well-known brands like Aldactone, Serenace, Naprosyn, and Azoran.
RPG Life Sciences focuses on delivering quality and innovation in the pharmaceutical industry, aiming to address diverse medical needs with its comprehensive product portfolio.
Check our website for more Q1 results.
RPG Life Sciences Q1 Results - FAQs
1. What are the Q1 2024-2025 results for RPG Life Sciences?
RPG Life Sciences reported a revenue of ₹16,542 lakhs, a profit for the period of ₹2,676 lakhs, and earnings per share of ₹16.18.
2. How did RPG Life Sciences’ revenue change in Q1 2024-2025?
RPG Life Sciences’ revenue increased by 30.54% from ₹12,699 lakhs in the previous quarter to ₹16,542 lakhs.
3. What was the profit before tax for RPG Life Sciences in Q1 2024-2025?
RPG Life Sciences reported a profit before tax of ₹3,600 lakhs.
4. What is the percentage increase in profit for the period year-over-year for RPG Life Sciences?
The profit for the period increased by 102.54% year-over-year.
5. How much did RPG Life Sciences spend on total expenses in Q1 2024-2025?
RPG Life Sciences’ total expenses for Q1 2024-2025 were ₹13,179 lakhs.
6. What was the total comprehensive income for RPG Life Sciences in Q1 2024-2025?
The total comprehensive income for RPG Life Sciences was ₹2,677 lakhs.
7. What was the other income for RPG Life Sciences in Q1 2024-2025?
RPG Life Sciences reported other income of ₹237 lakhs.
8. What were the total income and expenses for RPG Life Sciences in Q1 2024-2025?
The total income was ₹16,779 lakhs, and the total expenses were ₹13,179 lakhs.
9. What was the income tax expense for RPG Life Sciences in Q1 2024-2025?
The income tax expense was ₹924 lakhs.
10. What was the total income for RPG Life Sciences in the previous quarter?
The total income in the previous quarter was ₹12,864 lakhs.